Related Experiment Video
Updated: Jul 17, 2026

09:36
Applications of Liquid-Chromatography Tandem Mass Spectrometry in Natural Products Research: Tropane Alkaloids as a Case Study
Published on: March 8, 2024
A new lanostane-type triterpenoid from Chamaesyce prostrata.
S Rojas1, M Macías, P Castañeda
1Departamento de Farmacia, Facultad de Química, Universidad Nacional Autónoma de México, Coyoacán, México.
Planta Medica
|January 30, 2007
Summary
Researchers isolated a novel triterpenoid, lanost-25-en-3-beta-ol, and two known flavonoids from Chamaesyce prostrate. Structural elucidation was achieved using comprehensive spectral data analysis.
Area of Science:
- Phytochemistry
- Natural Products Chemistry
- Organic Chemistry
Background:
- Chamaesyce prostrate (Euphorbiaceae) is a plant species with potential medicinal properties.
- The chemical constituents of this plant have not been fully explored.
Purpose of the Study:
- To isolate and characterize chemical compounds from the aerial parts of Chamaesyce prostrate.
- To identify novel natural products and known bioactive secondary metabolites.
Main Methods:
- Phytochemical investigation of the aerial parts of Chamaesyce prostrate.
- Isolation of compounds using chromatographic techniques.
- Structure elucidation of the isolated compounds utilizing spectroscopic methods (e.g., NMR, MS).
Main Results:
- A new triterpenoid, lanost-25-en-3-beta-ol, was identified.
- Two known flavonoids, kaempferol-3,6-dimethyl ether and kaempferol 7-O-glucoside, were also isolated.
- The structure of the novel triterpenoid was confirmed through detailed spectral analysis.
Conclusions:
- The study successfully identified a new triterpenoid and two known flavonoids from Chamaesyce prostrate.
- These findings contribute to the phytochemical knowledge of the Euphorbiaceae family.
- Further research may explore the biological activities of these isolated compounds.
Related Concept Videos
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
Prochirality
The concept of prochirality leads to the nomenclature of the individual faces of a molecule and plays a crucial role in the enantioselective reaction. It is a concept where two or more achiral molecules react to produce chiral products. A typical process is the reaction of an achiral ketone to generate a chiral alcohol. Here, the achiral reactant reacts with an achiral reducing agent, sodium borohydride, to generate an equimolar mixture of the chiral enantiomers of the product. For example, an...

